Who can use Tysabri(Natalizumab)?

It is indicated for the monotherapy of relapsing multiple sclerosis in adults, as well as the induction and maintenance treatment of moderately to severely active Crohn's disease. For patients with Crohn's disease (CD), concurrent use with immunosuppressants or TNF-α inhibitors is not allowed.

Natalizumab(Tysabri)
It is indicated for the monotherapy of relapsing multiple sclerosis in adults, as well as the induction and maintenance treatment of moderately to severely active Crohn's disease.
RELATED ARTICLES
Indications for Natalizumab

Natalizumab is an important biologic agent produced by Biogen Idec. As a recombinant humanized IgG4κ monoclonal...

Tuesday, October 14th, 2025, 16:28
Indications for Natalizumab

Natalizumab is a recombinant humanized IgG4κ monoclonal antibody, manufactured by Biogen Idec Inc. As an important...

Friday, September 26th, 2025, 15:16
Indications of Natalizumab

Natalizumab is an important biologic agent produced by Biogen Idec. As a recombinant humanized IgG4κ monoclonal...

Thursday, September 18th, 2025, 16:13
/ 2
5 in total
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved